Biotech Values

[DewDiligence]

…reduced irreparable harm due to AG

The trigger of an AG launch is only one component of MNTA’s argument for irreparable harm, and it’s a relatively minor component of the argument, as you can see if you read the pleadings.

Inasmuch as SNY has always had the right to launch an AG irrespective of what Amphastar (or any other company) does, I doubt that MNTA’s argument about the threat of an AG launch would have figured into the Judge’s thinking on a PI in a material way. Hence, the Judge’s calculus on whether to issue a PI hasn’t materially changed since last Friday, IMO, despite your protestations to the contrary.